Angela Morriss

Angela Baggett Morriss , MD

Associate Professor of Clinical

One Stetson Square

2336

COM Neurology General Neurology - 0525

Education

Bachelor's Degree: Messiah College Grantham, Pennsylvannia, 1993 (Biology - Summa cum laude)

Medical Degree: Milton S. Hershey College of Medicine, Pennsylvania State Hershey, PA, 1999

Internship: University of Michigan Ann Arbor, MI, 2000 (Internal Medicine)

Residency: University of Michigan Ann Arbor, MI, 2003 (Neurology )

Fellowship: University of Michigan Ann Arbor, MI, 2004 (Epilepsy )

Certifications

American Board of Psychiatry and Neurology (Epilepsy) (Certification Date: 08-11-2014 )

American Board of Psychiatry and Neurology (Neurology) (Certification Date: 06-10-2005 )

Clinical Interests

Neurology

Specialities

Epilepsy

Neurology

Positions and Work Experience

03-01-2014 -02-28-2020 Staff Physician, Neurologist, Cincinnati Veteran's Administration Medical Center, Cincinnati, OH

03-01-2020 - Associate Professor, Division Director, General and Hospitalist Medicine, University of Cincinnati Department of Neurology, Cincinnati, OH

09-01-2015 -02-28-2020 Volunteer Professor, University of Cincinnati Department of Neurology, Cincinnati, OH

08-01-2012 -02-28-2014 Staff Neurologist, Group Health Associates, Cincinnati, OH

05-01-2008 -07-01-2012 Staff Physician, Neurologist, Cincinnati Veteran's Administration Medical Center, Cincinnati, OH

08-01-2004 -06-01-2006 Assistant Professor of Neurology, Cincinnati Epilepsy Center, University of Cincinnati Department of Neurology, Cincinnati, OH

Research Support

Investigators:Riegler, L.R., Morriss, A. 2018 Office of Rural Health Clinical Video Telehealth to Provide Comprehensive Care to Rural Veterans with Multiple Sclerosis.

1998 -2006 Parke-Davis Pregabalin open-label add-on trial: an open label, multicenter follow-on study to determine long-term safety and efficacy in patients with partial seizures Role:Sub-Investigator

2002 -2005 IVAX Laboratories Efficacy and safety of Talampanel as adjunctive therapy in patients with partial seizures: A Phase II clinical trial. Role:Sub-Principal Investigator

2002 -2006 Schwarz Biosciences An open-label, extension trial to determine tolerability and efficacy of long-term oral SPM 927 as adjunctive therapy in patients with partial seizures. Role:Sub-Investigator

2002 -2006 IVAX Laboratories Talampanel Open-Label Adjunctive Therapy: A Follow-On Study to Determine Long-Term Safety and Efficacy in Patients with Partial Seizures

Publications

Peer Reviewed Publications

V.P. Bhavananandan, Angela Martin (Morriss), Deborah R. Erickson (1996. ) “Quantitation of urinary glycosaminoglycans with Alcian blue: evaluation of the interference by Tamm-Horsfall glycoprotein.” .Clinica Chimica Acta, , (251 ) ,207 --214

Deborah R. Erickson, Sarah Ordille, Angela Martin (Morriss), V.P. Bhavanandan (1997. ) “Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.” .The Journal of Urology, , (157 ) ,61 --64

Szarflarski, JP, Holland, SK, Schmithorst VJ, Privitera MP, Ficker DF, Cahill JL, Meckler JM, Morriss AB (2005. ) “Comprehensive fMRI language evaluation in epilepsy patients” .Epilepsia, , 46 (8 ) ,46 --47

Presentations

Lecture

Angela Morriss, MD Antiepileptics in Clinical Practice .University of Cincinnati. UC. Level:University

Angela Morriss, MD (2013. ) Update on Migraine Management .Good Samaritan Hospital, Cincinnati, OH. Other Institution. Level:Local

Angela Morriss, MD (2013. ) Evaluation and Management of Transverse Myelitis .Cincinnati, OH. Other Institution. Level:Local

Angela Morriss, MD (2010. ) Seizure Semiology .University of Cincinnati. UC. Level:University

Angela Morriss, MD (2005. ) Surgical Options for Medication Resistant Non-lesional Epilepsy .Cincinnati. UC. Level:Department

Angela Morriss, MD (2005. ) The Management of Epilepsy in Women .University of Cincinnati. UC. Level:Department

Professional Affiliation

Member American Academy of Neurology,

Member Alpha Omega Alpha Honor Society,

Member VA Epilepsy Consortium,